| Code | Description | Claims | Beneficiaries | Total Paid |
| J0490 |
Injection, belimumab, 10 mg |
1,238 |
914 |
$3.56M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,542 |
21,418 |
$1.88M |
| J0491 |
Injection, anifrolumab-fnia, 1 mg |
290 |
278 |
$1.23M |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
824 |
607 |
$1.02M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,435 |
6,109 |
$480K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
657 |
422 |
$327K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,982 |
1,982 |
$244K |
| 86235 |
|
1,269 |
1,267 |
$195K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,261 |
2,249 |
$133K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
54 |
50 |
$109K |
| 80053 |
Comprehensive metabolic panel |
10,479 |
10,456 |
$95K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,308 |
5,948 |
$86K |
| 99205 |
Prolong outpt/office vis |
443 |
443 |
$77K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,372 |
11,348 |
$75K |
| 86140 |
|
13,709 |
13,692 |
$61K |
| 86480 |
|
960 |
958 |
$52K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
30 |
28 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,963 |
1,953 |
$33K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
3,225 |
3,047 |
$32K |
| 85652 |
|
12,372 |
12,355 |
$29K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
801 |
676 |
$21K |
| 73130 |
|
691 |
351 |
$20K |
| 96415 |
|
1,152 |
1,103 |
$19K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,835 |
1,829 |
$18K |
| 73560 |
|
690 |
354 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
684 |
684 |
$17K |
| 73620 |
|
682 |
360 |
$15K |
| 86225 |
|
1,279 |
1,279 |
$15K |
| 86200 |
|
1,288 |
1,288 |
$14K |
| 86038 |
|
1,275 |
1,275 |
$13K |
| 73120 |
|
603 |
455 |
$13K |
| 80050 |
General health panel |
416 |
416 |
$12K |
| 72052 |
|
243 |
243 |
$12K |
| 86803 |
|
948 |
948 |
$12K |
| 73521 |
|
338 |
338 |
$11K |
| 86704 |
|
985 |
985 |
$10K |
| 86160 |
|
476 |
476 |
$10K |
| 73565 |
|
314 |
314 |
$10K |
| 82728 |
|
789 |
789 |
$9K |
| 86706 |
|
943 |
943 |
$9K |
| 87340 |
|
941 |
941 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,969 |
1,865 |
$8K |
| 84481 |
|
476 |
476 |
$7K |
| 86431 |
|
1,205 |
1,205 |
$6K |
| 83550 |
|
783 |
783 |
$6K |
| 72110 |
|
131 |
131 |
$5K |
| 72100 |
|
143 |
143 |
$5K |
| 83540 |
|
782 |
782 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
448 |
448 |
$4K |
| 84439 |
|
463 |
463 |
$4K |
| 80061 |
Lipid panel |
256 |
256 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,052 |
2,004 |
$3K |
| 92083 |
|
43 |
43 |
$2K |
| 82607 |
|
112 |
112 |
$1K |
| 82746 |
|
112 |
112 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
52 |
51 |
$907.60 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
91 |
91 |
$851.80 |
| 73630 |
|
28 |
25 |
$757.19 |
| 72202 |
|
24 |
24 |
$746.90 |
| 84550 |
|
181 |
181 |
$716.36 |
| 71046 |
Radiologic examination, chest; 2 views |
28 |
28 |
$712.26 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
460 |
444 |
$673.30 |
| 82570 |
|
80 |
80 |
$360.33 |
| 82550 |
|
49 |
49 |
$272.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
463 |
426 |
$131.32 |